Remission of HCV-associated glomerulonephritis with pegylated IFN and ribavirin therapy after liver transplantation: Case report and literature review

International Journal of Artificial Organs

Volumn 36, Issue 1, 2013, Pages 63-68

  Donato, Maria Francesca ^a   Fabrizi, Fabrizio ^b   Fogazzi, Giovanni Battista ^b   Cresseri, Donata ^b   Passerini, Patrizia ^b   Martin, Paul ^c   Messa, Piergiorgio ^b  

^a FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^b IRCCS   (Italy)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

Author keywords

Glomerulonephritis; HCV RNA; Hepatitis C; Liver transplantation; Ribavirin

Indexed keywords

PATIENT TREATMENT; VIRUSES;

ANTIVIRAL THERAPY; CASE REPORTS; GLOMERULONEPHRITIS; HCV RNA; HEPATITIS C; KIDNEY FUNCTION; LIVER TRANSPLANTATION; MONO-THERAPY; PEGYLATED; RIBAVIRIN;

AMIDES;

AMLODIPINE; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTINUCLEAR ANTIBODY; BILIRUBIN; CALCIUM ANTAGONIST; CLONIDINE; CREATININE; CRYOGLOBULIN; FERROUS SULFATE; GAMMA GLUTAMYLTRANSFERASE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NEUTROPHIL CYTOPLASMIC ANTIBODY; OMEPRAZOLE; PEGINTERFERON ALPHA2A; RECOMBINANT ERYTHROPOIETIN; RHEUMATOID FACTOR; RIBAVIRIN; TACROLIMUS;

ADD ON THERAPY; ADULT; ARTICLE; BILIARY STENT; CASE REPORT; DEPRESSION; DISEASE ASSOCIATION; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; GLOMERULONEPHRITIS; HEMATURIA; HEPATITIS C; HISTOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; INFLUENZA; INSOMNIA; KIDNEY BIOPSY; LIVER BIOPSY; LIVER TRANSPLANTATION; MALE; MONOTHERAPY; NEPHRITIS; PHASE CONTRAST MICROSCOPY; PROTEINURIA; REMISSION; SIDE EFFECT; STENOSIS; VIRAL CLEARANCE; WEIGHT REDUCTION;

EID: 84874221258     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/ijao.5000166     Document Type: Article

References (34)

1. Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med. 2001;345(1):41-52.
2. Fabrizi F, Colucci P, Ponticelli C, Locatelli F. Kidney and liv-er involvement in cryoglobulinemia. Semin Nephrol. 2002; 22(4):309-318.
3. Johnson RJ, Willson R, Yamabe H, et al. Renal manifestations of hepatitis C virus infection. Kidney Int. 1994;46(5):1255-1263.
4. El-Serag HB, Hampel H, Yeh C, Rabeneck L. Extrahepatic manifestations of hepatitis C among United States male vet-erans. Hepatology. 2002;36(6):1439-1445.
5. National Kidney Foundation. Improving Global Outcomes. KDIGO clinical practice guidelines for the prevention, diag-nosis, evaluation, and treatment of Hepatitis C in chronic kidney disease. Kidney Int. 2008;73(Suppl 109):1-99. Ac-cessed October 12, 2012.
6. Fabrizi F, Lunghi G, Messa PG, Martin P. Therapy of hepatitis C virus-associated glomerulonephritis: current approaches. J Nephrol. 2008;21(6):813-825.
7. Kamar N, Rostaing L, Alric L. Treatment of hepatitis C-virus-related glomerulonephritis. Kidney Int. 2006;69(3):436-439.
8. Perico N, Cattaneo D, Bikbov B, Remuzzi G. Hepatitis C in-fection and chronic renal diseases. Clin J Am Soc Nephrol. 2009;4(1):207-220.
9. Coroneos E, Petrusevska G, Varghese F, Truong LD. Focal segmental glomerulosclerosis with acute renal failure as-sociated with alpha-interferon therapy. Am J Kidney Dis. 1996;28(6):888-892.
10. Ohta S, Yokoyama H, Wada T, et al. Exacerbation of glo-merulonephritis in subjects with chronic hepatitis C virus in-fection after interferon therapy. Am J Kidney Dis. 1999;33(6): 1040-1048.
11. Dimitrov Y, Heibel F, Marcellin L, Chantrel F, Moulin B, Hannedouche T. Acute renal failure and nephrotic syndrome with alpha interferon therapy. Nephrol Dial Transplant. 1997; 12(1):200-203.
12. Pascual M, Thadhani R, Chung RT, et al. Nephrotic syn-drome after liver transplantation in a patient with hepatitis C virus-associated glomerulonephritis. Transplantation. 1997; 64(7):1073-1076.
13. Baid S, Cosimi AB, Tolkoff-Rubin N, Colvin RB, Williams WW, Pascual M. Renal disease associated with hepatitis C infection after kidney and liver transplantation. Transplanta-tion. 2000;70(2):255-261.
14. Kendrick EA, McVicar JP, Kowdley KV, et al. Renal disease in hepatitis C-positive liver transplant recipients. Transplanta-tion. 1997;63(9):1287-1293.
15. Montalbano M, Pasulo L, Sonzogni A, Remuzzi G, Colledan M, Strazzabosco M. Treatment with pegylated interferon and ribavirin for hepatitis C virus-associated severe cryoglobuli-nemia in a liver/kidney transplant recipient. J Clin Gastroen-terol. 2007;41(2):216-220.
16. Davis CL, Gretch DR, Perkins JD, et al. Hepatitis C-associ-ated glomerular disease in liver transplant recipients. Liver Transpl Surg. 1995;1(3):166-175.
17. Sikaneta T, Williams WW, Chung RT, Cosimi AB, Pascual AM. Remission of hepatitis C virus-associated cryoglobulin-emic glomerulonephritis with interferon alfa-2b and ribavirin combination therapy after liver transplantation. Transplanta-tion. 2002;74(12):1767-1768.
18. Johnson RJ, Gretch DR, Couser WG, et al. Hepatitis C virus-associated glomerulonephritis. Effect of alpha-interferon therapy. Kidney Int. 1994;46(6):1700-1704.
19. Misiani R, Bellavita P, Fenili D, et al. Interferon alfa-2a ther-apy in cryoglobulinemia associated with hepatitis C virus. N Engl J Med. 1994;330(11):751-756.
20. D'Amico G. Renal involvement in hepatitis C infection: cryoglobulinemic glomerulonephritis. Kidney Int. 1998;54(2): 650-671.
21. Al-Wakeel J, Mitwalli A, Tarif N, Al-Mohaya S, Malik G, Khalil M. Role of interferon-alpha in the treatment of pri-mary glomerulonephritis. Am J Kidney Dis. 1999;33(6): 1142-1146.
22. Bruchfeld A, Lindahl K, Ståhle L, Söderberg M, Schvarcz R. Interferon and ribavirin treatment in patients with hepa-titis C-associated renal disease and renal insufficiency. Nephrol Dial Transplant. 2003;18(8):1573-1580.
23. Rossi P, Bertani T, Baio P, et al. Hepatitis C virus-related cryoglobulinemic glomerulonephritis: long-term remission after antiviral therapy. Kidney Int. 2003;63(6): 2236-2241.
24. Alric L, Plaisier E, Thébault S, et al. Influence of antiviral ther-apy in hepatitis C virus-associated cryoglobulinemic MPGN. Am J Kidney Dis. 2004;43(4):617-623.
25. Garini G, Allegri L, Lannuzzella F, Vaglio A, Buzio C. HCV-related cryoglobulinemic glomerulonephritis: implications of antiviral and immunosuppressive therapies. Acta Biomed. 2007;78(1):51-59.
26. Roccatello D, Fornasieri A, Giachino O, et al. Multicenter study on hepatitis C virus-related cryoglobulinemic glomeru-lonephritis. Am J Kidney Dis. 2007;49(1):69-82.
27. Abbas G, Hussain S, Shafi T. Effect of antiviral therapy on hepatitis C virus related glomerulopathy. Saudi J Kidney Dis Transpl. 2008;19(5):775-780.
28. Colucci G, Manno C, Grandaliano G, Schena FP. Cryoglobu-linemic membranoproliferative glomerulonephritis: beyond conventional therapy. Clin Nephrol. 2011;75(4):374-379.
29. Patterson JL, Fernandez-Larsson R. Molecular mechanisms of action of ribavirin. Rev Infect Dis. 1990;12(6):1139-1146.
30. Lau JY, Tam RC, Liang TJ, Hong Z. Mechanism of action of ribavirin in the combination treatment of chronic HCV infec-tion. Hepatology. 2002;35(5):1002-1009.
31. Pham HP, Féray C, Samuel D, et al. Effects of ribavirin on hepatitis C-associated nephrotic syndrome in four liver transplant recipients. Kidney Int. 1998;54(4):1311-1319.
32. Hu SL, Jaber BL. Ribavirin monotherapy for hepatitis C virus-associated membranous nephropathy. Clin Nephrol. 2005; 63(1):41-45.
33. Kamar N, Sandres-Saune K, Selves J, et al. Long-term rib-avirin therapy in hepatitis C virus-positive renal transplant patients: effects on renal function and liver histology. Am J Kidney Dis. 2003;42(1):184-192.
34. Durand JM, Cacoub P, Lunel-Fabiani F, et al. Ribavirin in hepatitis C related cryoglobulinemia. J Rheumatol. 1998; 25(6):1115-1117.